The ASX 50 blue-chip shares have had a few mixed performances in 2019.
Fortescue Metals Group Limited (ASX: FMG) shares have been arguably the top-performing shares on the ASX 50 after rocketing 163.86% higher in 2019.
Medibank Private Ltd (ASX: MPL) has led the ASX 50 insurers, while Commonwealth Bank of Australia Ltd (ASX: CBA) is the pick of the Big Four banks.
If you're looking to add some ASX 50 blue-chip shares to your portfolio in 2020, here are 3 starting options below.
Qantas Airways Limited (ASX: QAN)
The Aussie airline's shares could be at the right price after a 27.60% gain this year.
Qantas is an ASX 50 blue-chip share that could have a place in a diversified portfolio next year. It's worth noting that the group is susceptible to changes in global oil prices, which presents a potential hurdle in 2020.
However, Qantas shares are yielding a tidy 3.40% and outperformed the ASX 200 in 2019, which could make them a buy next year.
CSL Limited (ASX: CSL)
The CSL share price has been going from strength to strength in 2019.
The Aussie medical group has posted strong earnings and consistent R&D developments to fuel its share price higher. There's no doubt it is an ASX 50 blue-chip share after its meteoric rise in recent years.
CSL does pay a 0.82% dividend yield, but I think its upside growth potential is where the real value is at. The only question mark is its current price-to-earnings ratio of 45.6 times, which may indicate it is a little overbought right now.
Mirvac Group (ASX: MGR)
The Mirvac share price has been outperforming the S&P/ASX 200 (INDEXASX: XJO) this year as the Aussie real estate investment trust (A-REIT) cashes in on low interest rates.
Mirvac shares are up 47.27% this year compared to 22.64% for the benchmark index, with a rebound in residential real estate particularly beneficial.
With the property market booming again and cheap credit available to buyers, Mirvac could be one ASX 50 blue-chip share to watch in 2020.
